naltrexone has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raknes, G; Simonsen, P; Småbrekke, L | 1 |
| Dehpour, AR; Fakhraei, N; Hashemizadeh, S; Javadian, N; Nili, F; Rahimi, N; Rahimian, R | 1 |
2 other study(ies) available for naltrexone and Colitis Gravis
| Article | Year |
|---|---|
The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Databases, Factual; Drug Prescriptions; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Norway; Off-Label Use; Tumor Necrosis Factor-alpha | 2018 |
Involvement of central opioid receptors in protective effects of methadone on experimental colitis in rats.
Topics: Acetic Acid; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Injections, Intraventricular; Injections, Subcutaneous; Interleukin-1beta; Intestinal Mucosa; Male; Methadone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid; Tumor Necrosis Factor-alpha | 2018 |